USEUROPEAFRICAASIA 中文双语Français
Business
Home / Business / Industries

China OKs H7N9 test reagents for market entry

Xinhua | Updated: 2013-05-22 18:35

BEIJING - Two reagents used to conduct clinical tests for human infections of the H7N9 avian flu have been given approval to enter the Chinese market, according to the country's drug watchdog.

The two products, respectively developed by Shanghai ZJ Bio-Tech Co Ltd and DAAN Gene Co Ltd of Sun Yat-sen University, were approved Tuesday by the China Food and Drug Administration, according to a Wednesday circular issued by the administration.

Both products use fluorescent polymerase chain reaction (PCR), a biochemical technology that can locate bits of genetic material unique to the virus and amplify them for easy identification with the help of fluorescent markers.

According to the circular, the products can detect the presence of H7N9 in samples of respiratory secretions.

The latest official figures show that the Chinese mainland had reported 130 confirmed H7N9 cases, of which 36 ended in death, as of May 20. Seventy-two patients have recovered and been discharged from hospitals.

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US